Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reticular Pseudodrusen Progression Study

NCT02345317 is registered in ClinicalTrials.gov with University Hospital Muenster as lead sponsor.

NCT NCT02345317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02345317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reticular Pseudodrusen Progression Study
Lead sponsor
University Hospital Muenster
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2014
Completion date
Not reported
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration